BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8649322)

  • 1. Treatment of endodermal sinus tumor in children using a regimen that lacks bleomycin.
    Frazier AL; Grier HE; Green DM
    Med Pediatr Oncol; 1996 Aug; 27(2):69-73. PubMed ID: 8649322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor.
    Kang H; Kim TJ; Kim WY; Choi CH; Lee JW; Kim BG; Bae DS
    Gynecol Oncol; 2008 Oct; 111(1):106-10. PubMed ID: 18656249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of ovarian endodermal sinus tumor.
    Lian L; Huang H; Huang R; Lang J
    Chin Med J (Engl); 1996 May; 109(5):344-8. PubMed ID: 9208488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Response of ovarian endodermal sinus tumor to combination chemotherapy with cis-platinum, vincristine and bleomycin or vincristine, actinomycin and cyclophosphamide].
    Huang H; Lian L; Huang R
    Zhonghua Fu Chan Ke Za Zhi; 1995 May; 30(5):265-9. PubMed ID: 7544256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservative treatment and long-term follow up of endodermal sinus tumor of the vagina.
    Tao T; Yang J; Cao D; Guo L; Chen J; Lang J; Shen K
    Gynecol Oncol; 2012 May; 125(2):358-61. PubMed ID: 22178761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and treatment of endodermal sinus tumor of the vagina].
    Shen K; Huang R; Lang J
    Zhonghua Fu Chan Ke Za Zhi; 1999 Feb; 34(2):105-7. PubMed ID: 11263194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of childhood genital malignancies].
    Shen K; Lang J; Huang H
    Zhonghua Fu Chan Ke Za Zhi; 2001 Jun; 36(6):360-3. PubMed ID: 11783136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroblastoma.
    Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
    Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination chemotherapy with POMB/ACE (cisplatin, vincristine, methotrexate, bleomycin, actinomycin D, cyclophosphamide, etoposide) in advanced non-seminomatous testicular tumor].
    Masuda F; Kawahara M; Asano K; Shirakawa H
    Gan To Kagaku Ryoho; 1995 Oct; 22(12):1847-50. PubMed ID: 7574821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary chemotherapy for intracranial nongerminomatous germ cell tumors: results of the second international CNS germ cell study group protocol.
    Kellie SJ; Boyce H; Dunkel IJ; Diez B; Rosenblum M; Brualdi L; Finlay JL
    J Clin Oncol; 2004 Mar; 22(5):846-53. PubMed ID: 14990640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy in the management of ovarian germ cell malignancies.
    Schwartz PE
    Obstet Gynecol; 1984 Oct; 64(4):564-72. PubMed ID: 6207473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case report of a 6-year-old boy with intracranial yolk sac tumor treated by VAB-6 regimen].
    Wada H; Kubo M; Wada T; Ueno Y; Horita S; Ohki T; Munemoto S; Kuroda E; Taguchi H; Muramatsu N
    No Shinkei Geka; 1995 Jan; 23(1):65-8. PubMed ID: 7531296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
    Cushing B; Giller R; Cullen JW; Marina NM; Lauer SJ; Olson TA; Rogers PC; Colombani P; Rescorla F; Billmire DF; Vinocur CD; Hawkins EP; Davis MM; Perlman EJ; London WB; Castleberry RP; ;
    J Clin Oncol; 2004 Jul; 22(13):2691-700. PubMed ID: 15226336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B; Bode U; von Schweinitz D
    Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endodermal sinus tumor of the vagina.
    Terenziani M; Spreafico F; Collini P; Meazza C; Massimino M; Piva L
    Pediatr Blood Cancer; 2007 May; 48(5):577-8. PubMed ID: 16200632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of 129 patients with advanced and recurrent malignant ovarian germ cell tumor].
    Hong W; Zhang R; Liu L
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jan; 33(1):35-7. PubMed ID: 10682456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.
    Malogolowkin M; Cotton CA; Green DM; Breslow NE; Perlman E; Miser J; Ritchey ML; Thomas PR; Grundy PE; D'Angio GJ; Beckwith JB; Shamberger RC; Haase GM; Donaldson M; Weetman R; Coppes MJ; Shearer P; Coccia P; Kletzel M; Macklis R; Tomlinson G; Huff V; Newbury R; Weeks D;
    Pediatr Blood Cancer; 2008 Feb; 50(2):236-41. PubMed ID: 17539021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.